Somatic rearrangement of the tropomyosin-receptor-kinase (trk) oncogene is rare in gastrointestinal cancer
1988

Rare Activation of trk Oncogene in Gastrointestinal Cancer

Sample size: 86 publication Evidence: low

Author Information

Author(s): M.F. Fey, S.L. Thein

Primary Institution: Nuffield Department of Clinical Medicine, John Radcliffe Hospital

Hypothesis

Is the activation of the trk-oncogene by somatic DNA rearrangement a common feature of various human cancers, particularly gastrointestinal carcinomas?

Conclusion

The activation of the trk-oncogene by somatic gene rearrangement appears to be uncommon in gastrointestinal carcinomas.

Supporting Evidence

  • The trk oncogene was found only in tumor DNA and not in normal tissue, suggesting its relevance to cancer development.
  • None of the studied cases showed rearrangements at the tyrosine kinase locus.
  • Activation of oncogenes by somatic DNA rearrangement appears to be rare in human carcinomas.

Takeaway

Scientists looked at cancer samples to see if a specific gene was often changed in gastrointestinal cancers, but they found it was rare.

Methodology

DNA was extracted from various cancer tissues and analyzed using specific probes to detect gene rearrangements.

Limitations

The study may not have detected all possible rearrangements due to the restriction enzymes used.

Participant Demographics

The study included 46 cases of gastrointestinal carcinomas, 5 breast carcinomas, 1 urinary bladder carcinoma, 15 haematological malignancies, 4 colonic adenomas, 4 cases of Crohn's disease, and 11 normal individuals.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication